Arcoma

Arcoma Enterprise Value

The Enterprise Value (EV) of Arcoma (ARCOMA.ST) as of Oct 24, 2026 is 73.52 M SEK. In the previous year, Enterprise Value (EV) was 95.43 M SEK — a change of -22.96% (lower).

Enterprise Value

73.52 MSEK

YoY

-22.96%

Last updated:

Enterprise Value (EV) of Arcoma is 2025 73.52 M SEK. Enterprise Value (EV) of Arcoma was 2024 95.43 M SEK. It decreases by -22.96% lower compared to the previous year.

The Arcoma Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
114.28 M SEK
Jan 1, 2019
113.81 M SEK
Jan 1, 2020
117.17 M SEK
Jan 1, 2021
120.52 M SEK
Jan 1, 2022
124.18 M SEK
Jan 1, 2023
107.62 M SEK
Jan 1, 2024
95.43 M SEK
Jan 1, 2025
73.52 M SEK
The Arcoma Enterprise Value history
YEAREnterprise ValueYoY
73.52 MSEK-22.96%
95.43 MSEK-11.33%
107.62 MSEK-13.34%
124.18 MSEK+3.03%
120.52 MSEK+2.86%
117.17 MSEK+2.95%
113.81 MSEK-0.41%
114.28 MSEK+7.73%
106.09 MSEK-11.51%
119.88 MSEK+4.55%
114.67 MSEK-5.17%
120.92 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Enterprise Value (EV) of Arcoma is 73.52 M SEK in 2025.

Enterprise Value (EV) of Arcoma changed from 95.43 M SEK to 73.52 M SEK, representing a -22.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Arcoma since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s SEK, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' SEK varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Arcoma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Arcoma

All Key Metrics — Arcoma